Pfizer and BioNTech Announce Agreement with the United Kingdom for 30 Million Doses of mRNA-based Vaccine Candidate Against SARS-CoV-2
Go back to Pfizer and BioNTech Announce Agreement with the United Kingdom for 30 Million Doses of mRNA-based Vaccine Candidate Against SARS-CoV-2| (NASDAQ: BNTX) | Delayed: 98.00 +1.94 (2.02%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $96.06 | 52 Week High | $ | |||
| Open | $97.25 | 52 Week Low | $ | |||
| Day High | $98.98 | P/E | N/A | |||
| Day Low | $96.61 | EPS | $ | |||
| Volume | 800,847 | |||||
| Pfizer Inc. (NYSE: PFE) | Delayed: 27.74 +0.08 (0.29%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $27.66 | 52 Week High | $37.39 | |||
| Open | $27.65 | 52 Week Low | $28.25 | |||
| Day High | $27.92 | P/E | 16.81 | |||
| Day Low | $27.53 | EPS | $1.65 | |||
| Volume | 28,767,605 | |||||

